Back to Companies
Dermata Therapeutics, Inc.
DRMANasdaqCIK: 0001853816
Over the 15 most recent insider filings, Dermata Therapeutics, Inc. (DRMA) has seen activity from 11 distinct insiders — 1 buying and 1 selling. The activity is heavily weighted toward buying: $1.3K bought versus $13 sold, a net purchase of $1.3K. PROEHL GERALD T (President, CEO and Chairman, Director, 10% Owner) is the most active by dollar volume, and the single largest transaction was $3.7M by PROEHL GERALD T. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$4.5M
Purchases
$1.3K
Sales
$13
Unique Insiders
11
Recent Insider Trades
15 loaded
| Jun 16 | DRMA Dermata Therapeutics, Inc. | Scott Kathleen D. | Director | Sell | $13 |
| Mar 17 | DRMA Dermata Therapeutics, Inc. | Bedoya-Toro Munera Maria E | SVP, Regulatory Affairs | Buy | $1.3K |
| Jan 6 | DRMA Dermata Therapeutics, Inc. | PROEHL GERALD T | President, CEO and Chairman, Director, 10% Owner | Award | $81.8K |
| Jan 6 | DRMA Dermata Therapeutics, Inc. | Bradrick Brittany | Director | Award | $5.5K |
| Jan 6 | DRMA Dermata Therapeutics, Inc. | WIERENGA WENDELL | Director | Award | $5.5K |
| Jan 6 | DRMA Dermata Therapeutics, Inc. | Nardo Christopher J. | Senior VP, CDO | Award | $39.2K |
| Jan 6 | DRMA Dermata Therapeutics, Inc. | Mento Steven J | Director | Award | $5.5K |
| Jan 6 | DRMA Dermata Therapeutics, Inc. | Bedoya-Toro Munera Maria E | SVP, Regulatory Affairs | Award | $19.6K |
| Jan 6 | DRMA Dermata Therapeutics, Inc. | FISHER MARY | Director | Award | $5.5K |
| Jan 6 | DRMA Dermata Therapeutics, Inc. | HALE DAVID F | Director | Award | $5.5K |
| Jan 6 | DRMA Dermata Therapeutics, Inc. | Sandler Andrew Seth | Director | Award | $5.5K |
| Jan 6 | DRMA Dermata Therapeutics, Inc. | Scott Kathleen D. | Director | Award | $5.5K |
| Jan 6 | DRMA Dermata Therapeutics, Inc. | Van Hoose Kyri K. | SVP, CFO | Award | $39.2K |
| Dec 29 | DRMA Dermata Therapeutics, Inc. | Van Hoose Kyri K. | SVP, CFO | Grant | $616.1K |
| Dec 29 | DRMA Dermata Therapeutics, Inc. | PROEHL GERALD T | PRESIDENT, CHAIRMAN, CEO, Director, 10% Owner | Grant | $3.7M |
15 filings